0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastrointestinal Therapeutics and Diagnostics Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-14S13291
Home | Market Reports | Health| Health Conditions
Global Gastrointestinal Therapeutics and Diagnostics Market Research Report 2023
BUY CHAPTERS

Global Gastrointestinal Therapeutics and Diagnostics Market Research Report 2024

Code: QYRE-Auto-14S13291
Report
May 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gastrointestinal Therapeutics and Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastrointestinal Therapeutics and Diagnostics Market

Gastrointestinal Therapeutics and Diagnostics Market

Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.
The global Gastrointestinal Therapeutics and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Therapeutics and Diagnostics.

Report Scope

The Gastrointestinal Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gastrointestinal Therapeutics and Diagnostics Market Report

Report Metric Details
Report Name Gastrointestinal Therapeutics and Diagnostics Market
CAGR 5%
Segment by Type
  • Diagnostics
  • Therapeutics
Segment by Application
  • Gastroenteritis
  • GI Bleeding
  • Irritable Bowel Syndrome
  • Peptic Ulcer Disease (PUD)
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals, Takeda Pharmaceutical Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gastrointestinal Therapeutics and Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastrointestinal Therapeutics and Diagnostics Market report?

Ans: The main players in the Gastrointestinal Therapeutics and Diagnostics Market are Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals, Takeda Pharmaceutical Company

What are the Application segmentation covered in the Gastrointestinal Therapeutics and Diagnostics Market report?

Ans: The Applications covered in the Gastrointestinal Therapeutics and Diagnostics Market report are Gastroenteritis, GI Bleeding, Irritable Bowel Syndrome, Peptic Ulcer Disease (PUD), Others

What are the Type segmentation covered in the Gastrointestinal Therapeutics and Diagnostics Market report?

Ans: The Types covered in the Gastrointestinal Therapeutics and Diagnostics Market report are Diagnostics, Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gastroenteritis
1.3.3 GI Bleeding
1.3.4 Irritable Bowel Syndrome
1.3.5 Peptic Ulcer Disease (PUD)
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Perspective (2019-2030)
2.2 Gastrointestinal Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Gastrointestinal Therapeutics and Diagnostics Market Dynamics
2.3.1 Gastrointestinal Therapeutics and Diagnostics Industry Trends
2.3.2 Gastrointestinal Therapeutics and Diagnostics Market Drivers
2.3.3 Gastrointestinal Therapeutics and Diagnostics Market Challenges
2.3.4 Gastrointestinal Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Therapeutics and Diagnostics Revenue
3.4 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics and Diagnostics Revenue in 2023
3.5 Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)
5 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2019-2030)
6.2 North America Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2019-2024)
6.4 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2019-2030)
7.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2019-2024)
7.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size (2019-2030)
9.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Introduction
11.2.4 AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Eisai
11.3.1 Eisai Company Detail
11.3.2 Eisai Business Overview
11.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Introduction
11.3.4 Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
11.3.5 Eisai Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Introduction
11.4.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Detail
11.5.2 Salix Pharmaceuticals Business Overview
11.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Introduction
11.5.4 Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
11.5.5 Salix Pharmaceuticals Recent Development
11.6 Takeda Pharmaceutical Company
11.6.1 Takeda Pharmaceutical Company Company Detail
11.6.2 Takeda Pharmaceutical Company Business Overview
11.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Introduction
11.6.4 Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
11.6.5 Takeda Pharmaceutical Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Diagnostics
    Table 3. Key Players of Therapeutics
    Table 4. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2019-2024)
    Table 8. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2025-2030)
    Table 10. Gastrointestinal Therapeutics and Diagnostics Market Trends
    Table 11. Gastrointestinal Therapeutics and Diagnostics Market Drivers
    Table 12. Gastrointestinal Therapeutics and Diagnostics Market Challenges
    Table 13. Gastrointestinal Therapeutics and Diagnostics Market Restraints
    Table 14. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players (2019-2024)
    Table 16. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2023)
    Table 17. Ranking of Global Top Gastrointestinal Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
    Table 21. Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)
    Table 25. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)
    Table 27. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2019-2024)
    Table 29. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2025-2030)
    Table 31. North America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Abbott Laboratories Company Detail
    Table 47. Abbott Laboratories Business Overview
    Table 48. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product
    Table 49. Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
    Table 50. Abbott Laboratories Recent Development
    Table 51. AstraZeneca Company Detail
    Table 52. AstraZeneca Business Overview
    Table 53. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product
    Table 54. AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
    Table 55. AstraZeneca Recent Development
    Table 56. Eisai Company Detail
    Table 57. Eisai Business Overview
    Table 58. Eisai Gastrointestinal Therapeutics and Diagnostics Product
    Table 59. Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
    Table 60. Eisai Recent Development
    Table 61. Johnson & Johnson Company Detail
    Table 62. Johnson & Johnson Business Overview
    Table 63. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product
    Table 64. Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
    Table 65. Johnson & Johnson Recent Development
    Table 66. Salix Pharmaceuticals Company Detail
    Table 67. Salix Pharmaceuticals Business Overview
    Table 68. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product
    Table 69. Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
    Table 70. Salix Pharmaceuticals Recent Development
    Table 71. Takeda Pharmaceutical Company Company Detail
    Table 72. Takeda Pharmaceutical Company Business Overview
    Table 73. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product
    Table 74. Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
    Table 75. Takeda Pharmaceutical Company Recent Development
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030
    Figure 3. Diagnostics Features
    Figure 4. Therapeutics Features
    Figure 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030
    Figure 7. Gastroenteritis Case Studies
    Figure 8. GI Bleeding Case Studies
    Figure 9. Irritable Bowel Syndrome Case Studies
    Figure 10. Peptic Ulcer Disease (PUD) Case Studies
    Figure 11. Others Case Studies
    Figure 12. Gastrointestinal Therapeutics and Diagnostics Report Years Considered
    Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Gastrointestinal Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030
    Figure 16. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players in 2023
    Figure 17. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue in 2023
    Figure 19. North America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2019-2030)
    Figure 21. United States Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2019-2030)
    Figure 25. Germany Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2019-2030)
    Figure 33. China Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2019-2030)
    Figure 41. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2019-2030)
    Figure 45. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
    Figure 48. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
    Figure 49. Eisai Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
    Figure 50. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
    Figure 51. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
    Figure 52. Takeda Pharmaceutical Company Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2019-2024)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Blood Pressure Mointor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35U11386
Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Isosorbide Mononitrate and Glucose Injection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8U11347
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Automatic Blood Sugar Monitor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-21E11553
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Closed Chest Drainage Bag Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5M12588
Tue Jun 18 00:00:00 UTC 2024

Add to Cart